Vaccination
Vaccination is a crucial measure to protect individual and community health. Our medical centre offers a comprehensive range of vaccination services, including seasonal influenza vaccines, childhood immunizations, and adult vaccines, ensuring proper health protection for all age groups. All vaccinations are administered by qualified healthcare professionals following strict international safety standards.
We are committed to providing safe and effective vaccination services to our patients. Our professional healthcare team will provide appropriate vaccine recommendations and immunization schedules based on individual health conditions and needs, ensuring optimal immune protection for every patient.
Below vaccination services are now available
The following vaccination services are now available for appointment and consultation. Our healthcare team will provide detailed explanations about the effectiveness, vaccination schedules, and precautions for each vaccine, helping you make the most suitable health choices.
- For: Prevention of seasonal flu and its complications.
- Population: Adults and children from 6 months of age, especially those at higher risk (children, elderly, chronically ill).
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule:
- Adult: 1 dose (per year)
- Paediatric population:
- Children from 6 months to 17 years of age: 1 dose (per year)
- Children less than 9 years old, who have not previously been vaccinated with a seasonal influenza vaccine: 2 doses (current season; 4 weeks apart)
- Prevalence: Annual winter/summer outbreaks occur in Hong Kong, resulting in community and school clusters and hospital admissions.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, mild fever, and headache. Severe allergic reactions are rare and require emergency help.
- Abrysvo
- For: Prevention of RSV lower respiratory tract disease in infants (via maternal immunization) and adults 60+/high-risk adults 18–59.
- Population: Pregnant individuals (32–36 weeks gestation), adults 60+, adults 18–59 at increased risk.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose; once only (32–36 weeks gestation for pregnancy).
- Prevalence: Major cause of hospitalizations for infants/elderly in Hong Kong.
- Adverse Effects: Most people do not have serious reactions; common side effects include redness or swelling at the injection site and mild systemic symptoms. Severe allergic reactions like hives, swelling of lips or tongue, and breathing difficulties are rare and require emergency help.
- Arexvy
- For: Prevention of RSV lower respiratory tract disease in older adults.
- Population: Adults 60+, adults 50–59 at increased risk.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose; once only.
- Prevalence: Periodic seasonal outbreaks with hospitalizations in elderly.
- Adverse Effects: Most people do not have serious reactions; common side effects include redness, swelling at injection site, headache, and fatigue, which usually resolve within a few days. Severe allergic reactions are rare and require emergency help.
- For: Prevention of diphtheria, tetanus, and pertussis (whooping cough), often includes polio, hepatitis B, or Hib.
- Population: Children from 6 weeks of age and above.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Primary series at 2, 4, 6 months, with booster at 12–18 months and/or 18 months (or as per local guidelines).
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, redness, mild fever, and swelling at the injection site. Severe allergic reactions are rare and require emergency help.
- For: Booster/protection against diphtheria, tetanus, and pertussis.
- Population: Adolescents, adults, and pregnant women (usually at 20–32 weeks pregnancy or third trimester).
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Booster every 5–10 years; a single dose in each pregnancy.
- Adverse Effects: Most people do not have serious reactions; common side effects include redness, pain, headache, and mild fever. Severe allergic reactions are rare and require emergency help.
- Imovax polio
- For: Polio
- Population: 2 months+ (at risk, travelers).
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 3 doses, 1–2 months apart.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness and mild fever. Severe allergic reactions are rare and require emergency help.
- Hiberix
- For: Hib infection.
- Population: 6 weeks to 4 years.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 3 doses (2, 4, 6 months), booster at 15–18 months.
- Adverse Effects: Most people do not have serious reactions; common side effects include redness, soreness, and mild fever. Severe allergic reactions are rare and require emergency help.
- B.C.G.
- For: Severe TB prevention in children.
- Population: Infants >1 month, children.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose (birth/soon after if unvaccinated).
- Prevalence: Continues to circulate especially in older adults.
- Adverse Effects: Most people do not have serious reactions; common side effects include a small ulcer or sore at the injection site. Severe allergic reactions are rare and require emergency help.
- Menquadfi (ACWY)
- For: Invasive meningococcal ACWY.
- Population: 2+ years, at-risk, travelers.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose; booster every 5 years if risk persists, for those aged 7 years or older.
- Prevalence: Annual cases reported.
- Adverse Effects: Most people do not have serious reactions; common side effects include pain, headache, and mild fever. Severe allergic reactions are rare and require emergency help.
- Bexsero (B)
- For: Meningococcal group B.
- Population: Infants 2 months+, children, at-risk adults.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Age-specific (infants/children: 2–3 doses + booster).
- Prevalence: Annual cases reported.
- Adverse Effects: Most people do not have serious reactions; common side effects include fever (especially infants) and injection site symptoms. Severe allergic reactions are rare and require emergency help.
- Engerix-B
- For: Hepatitis B.
- Population: All ages.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule:
- Standard: 3 doses at 0, 1, and 6 months.
- Accelerated: 3 doses at 0, 1, and 2 months; booster at 12 months.
- Prevalence: ~1 in 18 carry HBV in Hong Kong, mostly aged 35+.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness and mild fever. Severe allergic reactions are rare and require emergency help.
- Twinrix Adult
- For: Hepatitis A & B combo.
- Population: 16+ years.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule:
- Standard: 3 doses at 0, 1, and 6 months.
- Accelerated: 4 doses at 0, 7, 21–30 days, and 12 months.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, headache, and mild fever. Severe allergic reactions are rare and require emergency help.
- Havrix 720/1440
- For: Hepatitis A.
- Population: 1–16 years (720), 16+ years (1440).
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose + booster 6–36 months later.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness and mild fever. Severe allergic reactions are rare and require emergency help.
- Gardasil-9
- For: Prevention of HPV cancers/warts.
- Population: 9–45 years.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 9–14 yrs: 2 doses 6–12 months apart; 15+: 3 doses (0, 2, 6 months).
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, fainting, and swelling at the injection site. Severe allergic reactions are rare and require emergency help.
- Imojev
- For: Japanese encephalitis.
- Population: 9 months+, travelers/rural.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose; booster 1–2 years later if continued risk in children, no booster required for adults for up to 5 years.
- Adverse Effects: Most people do not have serious reactions; common side effects include headache, soreness, and mild fever. Severe allergic reactions are rare and require emergency help.
- For: Prevention of measles, mumps, and rubella.
- Population: Children ≥12 months; adults needing catch-up.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 2 doses; first dose at 12–15 months, second at 4–6 years.
- Prevalence: Still causes sporadic local cases and outbreaks in Hong Kong annually.
- Adverse Effects: Most people do not have serious reactions; common side effects include mild rash, fever, and swelling. Severe allergic reactions are rare and require emergency help.
- For: Combined prevention of measles, mumps, rubella, and chickenpox (varicella).
- Population: Children aged 1 to 14 years.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 2 doses; first dose at 12–15 months, second at 4–6 years.
- Prevalence: All four targeted diseases are still observed in Hong Kong, especially among unvaccinated groups.
- Adverse Effects: Most people do not have serious reactions; common side effects include mild rash, fever, and localized swelling. Severe allergic reactions are rare and require emergency help.
- For: Prevention of chickenpox (varicella), a highly contagious viral disease.
- Population: Children ≥12 months; older children and adults without immunity.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule:
- Children: 2 doses—first at 12–15 months, second at 4–6 years
- Adolescents/adults (≥13 years): 2 doses at least 4 weeks apart
- Prevalence: Endemic in Hong Kong, with annual outbreaks in childcare centres, schools, and homes.
- Adverse Effects: Most people do not have serious reactions; common side effects include mild rash, fever, and soreness. Severe allergic reactions are rare and require emergency help.
- Pneumovax 23
- For: Invasive pneumococcal disease (23 serotypes).
- Population: 2+ years at risk, adults 65+.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 2 doses, 5–10 years apart; as booster one year after PCV15.
- Prevalence: Ongoing in children <5 and elderly.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, swelling, and mild fever. Severe allergic reactions are rare and require emergency help.
- Vaxneuvance
- For: 15-serotype pneumococcal disease.
- Population: Infants 6 weeks+, others as catch-up/at risk.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 4 doses as primary; catch-up per age.
- Prevalence: Ongoing in young/elderly.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness and mild fever. Severe allergic reactions are rare and require emergency help.
- Prevenar 20
- For: 20-serotype pneumococcal disease.
- Population: 6 weeks–15 months (children), 18+ (adults).
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule:
- 4 doses (children)
- Single dose (adults)
- Catch-up: For those behind schedule, catch up with appropriate number of doses for age until age 5
- Prevalence: Still present in at-risk populations.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, swelling, and mild fever. Severe allergic reactions are rare and require emergency help.
- Rotarix
- For: Rotavirus (oral).
- Population: 6–24 weeks.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 2 oral doses (6–14 weeks, before 25 weeks); ≥4 weeks apart.
- Prevalence: Major cause of infant GI admissions.
- Adverse Effects: Most people do not have serious reactions; common side effects include diarrhea, vomiting, and irritability. Severe allergic reactions are rare and require emergency help.
- Rotateq
- For: Rotavirus (oral).
- Population: 6–32 weeks.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 3 oral doses; first at 6–12 weeks, each 4–10 weeks apart, complete by 32 weeks.
- Prevalence: Major cause of infant/child GI admissions.
- Adverse Effects: Most people do not have serious reactions; common side effects include diarrhea, vomiting, and fussiness. Severe allergic reactions are rare and require emergency help.
- Shingrix
- For: Shingles prevention.
- Population: Adults ≥50, or ≥18 at high risk.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: 2 doses, 2–6 months apart.
- Prevalence: 1 in 3 adults in their lifetime, mostly 50+.
- Adverse Effects: Most people do not have serious reactions; common side effects include sore arm, fatigue, and fever. Severe allergic reactions are rare and require emergency help.
- Typhim VI
- For: Typhoid prevention (esp. for travelers).
- Population: 2+ years.
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Single dose, repeat every 2 years if ongoing risk.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, headache, and mild fever. Severe allergic reactions are rare and require emergency help.
- Verorab
- For: Rabies post-/pre-exposure.
- Population: All ages at risk (bite/travel).
- Doctor consultation may be required prior to administering specific vaccinations. For more information, please inquire with the staff when making your appointment.
- Schedule: Pre-exposure: 0, 7, 21(28); post-exposure per protocol.
- Adverse Effects: Most people do not have serious reactions; common side effects include soreness, fever, and headache. Severe allergic reactions are rare and require emergency help.
